Quantum dots - Nano-sized probes for the exploration of cellular and intracellular targeting

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 68, Issue 2, 2008, Pages 153-168

  Hild, W A ^a   Breunig, M ^a   Goepferich, A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cellular uptake; Cytotoxicity; Drug targeting; Endocytosis; Nanoparticle; Quantum dot

Indexed keywords

CADMIUM; CELL PENETRATING PEPTIDE; FOLATE RECEPTOR; G PROTEIN COUPLED RECEPTOR; INTEGRIN; MEMBRANE ANTIGEN; NANOPARTICLE; PROTEIN TYROSINE KINASE; QUANTUM DOT; TRANSFERRIN RECEPTOR;

COLLOID; CONJUGATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOCYTOSIS; HUMAN; IMAGING; LASER MICROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHAGE DISPLAY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSFERRIN BLOOD LEVEL; TRANSMISSION ELECTRON MICROSCOPY;

ENDOCYTOSIS; NANOTECHNOLOGY; QUANTUM DOTS; SENSITIVITY AND SPECIFICITY;

EID: 37849050131     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.06.009     Document Type: Review

References (150)

1. Torchilin V.P. Drug targeting. E. J. Pharmaceut. Sci. 11 (2000) S81-S91
2. Groneberg D.A., Giersig M., Welte T., and Pison U. Nanoparticle-based diagnosis and therapy. Curr. Drug Targets 7 (2006) 643-648
3. Owens D.E., and Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307 (2006) 93-102
4. Otsuka H., Nagasaki Y., and Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev. 55 (2003) 403-419
5. Vasir J., Reddy M., and Labhasetwar V. Nanosystems in drug targeting: opportunities and challenges. Curr. Nanosci. 1 (2005) 47-64
6. Khalil I.A., Kogure K., Akita H., and Harashima H. Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery. Pharmacol. Rev. 58 (2006) 32-45
7. Rabinow B., and Chaubal M.V. Injectable nanoparticles for efficient drug delivery. Drugs Pharmaceut. Sci. 159 (2006) 199-229
8. Osaki F., Kanamori T., Sando S., Sera T., and Aoyama Y. A quantum dot conjugated sugar ball and its cellular uptake. on the size effects of endocytosis in the subviral region. J. Am. Chem. Soc. 126 (2004) 6520-6521
9. Chang E., Yu W.W., Colvin V.L., and Drezek R. Quantifying the influence of surface coatings on quantum dot uptake in cells. J. Biomed. Nanotechnol. 1 (2005) 397-401
10. Chan W.C.W., and Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281 (1998) 2016-2018
11. Lidke D.S., Nagy P., Heintzmann R., Arndt-Jovin D.J., Post J.N., Grecco H.E., Jares-Erijman E.A., and Jovin T.M. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat. Biotechnol. 22 (2004) 198-203
12. Derfus A.M., Chan W.C.W., and Bhatia S.N. Intracellular delivery of quantum dots for live cell labeling and organelle tracking. Adv. Mater. 16 (2004) 961-966
13. Chen F., and Gerion D. Fluorescent CdSe/ZnS Nanocrystal-Peptide Conjugates for Long-term, Nontoxic Imaging and Nuclear Targeting in Living Cells. Nano Lett. 4 (2004) 1827-1832
14. Sharma P., Brown S., Walter G., Santra S., and Moudgil B. Nanoparticles for bioimaging. Adv. Colloid Interface Sci. 123-126 (2006) 471-485
15. Thorek Daniel L.J., Chen A.K., Czupryna J., and Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann. Biomed. Eng. 34 (2006) 23-38
16. Bonnemain B. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review. J. Drug Target. 6 (2004) 167-174
17. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., and Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 15 (2004) 79-86
18. Chithrani B.D., Ghazani A.A., and Chan W.C.W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6 (2006) 662-668
19. Gross S., and Piwnica-Worms D. Molecular imaging strategies for drug discovery and development. Curr. Opin. Chem. Biol. 10 (2006) 334-342
20. Dahan M., Levi S., Luccardini C., Rostaing P., Riveau B., and Triller A. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 302 (2003) 442-445
21. Peng Z.A., and Peng X. Formation of high-quality CdTe, CdSe, and CdS nanocrystals using CdO as precursor. J. Am. Chem. Soc. 123 (2001) 183-184
22. Smith A.M., and Nie S. Chemical analysis and cellular imaging with quantum dots. Analyst 129 (2004) 672
23. Bruchez Jr. M., Moronne M., Gin P., Weiss S., and Alivisatos A.P. Semiconductor nanocrystals as fluorescent biological labels. Science 281 (1998) 2013-2016
24. Jaiswal J.K., Mattoussi H., Mauro J.M., and Simon S.M. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 21 (2003) 47-51
25. Gao X., Yang L., Petros J.A., Marshall F.F., Simons J.W., and Nie S. In vivo molecular and cellular imaging with quantum dots. Curr. Opin. Biotechnol. 16 (2005) 63-72
26. Dahan M., Laurence T., Pinaud F., Chemla D.S., Alivisatos A.P., Sauer M., and Weiss S. Time-gated biological imaging by use of colloidal quantum dots. Opt. Lett. 26 (2001) 825-827
27. Costa-Fernandez J.M., Pereiro R., and Sanz-Medel A. The use of luminescent quantum dots for optical sensing. Trends Anal. Chem. 25 (2006) 207-218
28. Murray C.B., Norris D.J., and Bawendi M.G. Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites. J. Am. Chem. Soc. 115 (1993) 8706-8715
29. Hines M.A., and Guyot-Sionnest P. Synthesis and characterization of strongly luminescing zns-capped cdse nanocrystals. J. Phys. Chem. 100 (1996) 468-471
30. Dabbousi B.O., Rodriguez-Viejo J., Mikulec F.V., Heine J.R., Mattoussi H., Ober R., Jensen K.F., and Bawendi M.G. (CdSe)ZnS core-shell quantum dots: synthesis and optical and structural characterization of a size series of highly luminescent materials. J. Phys. Chem. B 101 (1997) 9463-9475
31. Michalet X., Pinaud F., Lacoste T.D., Dahan M., Bruchez M.P., Alivisatos A.P., and Weiss S. Properties of fluorescent semiconductor nanocrystals and their application to biological labeling. Single Mol. 2 (2001) 261-276
32. Kim S., Lim Y.T., Soltesz E.G., De Grand A.M., Lee J., Nakayama A., Parker J.A., Mihaljevic T., Laurence R.G., Dor D.M., Cohn L.H., Bawendi M.G., and Frangioni J.V. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 22 (2004) 93-97
33. Frangioni J.V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 7 (2003) 626-634
34. Ballou B. Quantum dot surfaces for use in vivo and in vitro. Curr. Top. Dev. Biol. 70 (2005) 103-120
35. Sahoo Y., Poddar P., Srikanth H., Lucey D.W., and Prasad P.N. Chemically fabricated magnetic quantum dots of inp:mn. J. Phys. Chem. B 109 (2005) 15221-15225
36. Mulder W.J.M., Koole R., Brandwijk R.J., Storm G., Chin P.T.K., Strijkers G.J., de Donega C., Nicolay K., and Griffioen A.W. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett. 6 (2006) 1-6
37. Prinzen L., Miserus R.J., Dirksen A., Hackeng T.M., Deckers N., Bitsch N.J., Megens R.T.A., Douma K., Heemskerk J.W., Kooi M.E., Frederik P.M., Slaaf D.W., van Zandvoort M.A.M.J., and Reutelingsperger C.P.M. Optical and magnetic resonance imaging of cell death and platelet activation using annexin a5-functionalized quantum dots. Nano Lett. 7 (2007) 93-100
38. So M.K., Xu C., Loening A.M., Gambhir S.S., and Rao J. Self-illuminating quantum dot conjugates for in vivo imaging. Nat. Biotechnol. 24 (2006) 339-343
39. Mattoussi H., Mauro J.M., Goldman E.R., Anderson G.P., Sundar V.C., Mikulec F.V., and Bawendi M.G. Self-assembly of CdSe-ZnS quantum dot bioconjugates using an engineered recombinant protein. J. Am. Chem. Soc. 122 (2000) 12142-12150
40. Kim S., and Bawendi M.G. Oligomeric ligands for luminescent and stable nanocrystal quantum dots. J. Am. Chem. Soc. 125 (2003) 14652-14653
41. Guo W., Li J.J., Wang Y.A., and Peng X. Conjugation chemistry and bioapplications of semiconductor box nanocrystals prepared via dendrimer bridging. Chem. Mater. 15 (2003) 3125-3133
42. Pinaud F., King D., Moore H.P., and Weiss S. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. J. Am. Chem. Soc. 126 (2004) 6115-6123
43. Mattoussi H., Mauro J.M., Goldman E.R., Anderson G.P., Sundar V.C., Mikulec F.V., and Bawendi M.G. Self-assembly of CdSe-ZnS quantum dot bioconjugates using an engineered recombinant protein. J. Am. Chem. Soc. 122 (2000) 12142-12150
44. Gerion D., Pinaud F., Williams S.C., Parak W.J., Zanchet D., Weiss S., and Alivisatos A.P. Synthesis and properties of biocompatible water-soluble silica-coated CdSe/ZnS semiconductor quantum dots. J. Phys. Chem. B 105 (2001) 8861-8871
45. Pellegrino T., Manna L., Kudera S., Liedl T., Koktysh D., Rogach A.L., Keller S., Raedler J., Natile G., and Parak W.J. Hydrophobic nanocrystals coated with an amphiphilic polymer shell: a general route to water soluble nanocrystals. Nano Lett. 4 (2004) 703-707
46. Gao X., Cui Y., Levenson R.M., Chung L.W.K., and Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22 (2004) 969-976
47. Dubertret B., Skourides P., Norris D.J., Noireaux V., Brivanlou A.H., and Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298 (2002) 1759-1762
48. Hezinger A., Tessmar J., and Goepferich A. Polymer coating of quantum dots - a powerful tool toward diagnostics and sensorics. Eur. J. Pharm. Biopharm. 68 (2008) 138-152
49. Wu X., Liu H., Liu J., Haley K.N., Treadway J.A., Larson J.P., Ge N., Peale F., and Bruchez M.P. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol. 21 (2003) 41-46
50. Zhang C., Ma H., Ding Y., Jin L., Chen D., and Nie S. Quantum dot-labeled trichosanthin. Analyst 125 (2000) 1029-1031
51. Srinivasan C., Lee J., Papadimitrakopoulos F., Silbart L.K., Zhao M., and Burgess D.J. Labeling and intracellular tracking of functionally active plasmid dna with semiconductor quantum dots. Mol. Ther. 14 (2006) 192-201
52. Parak W.J., Gerion D., Zanchet D., Woerz A.S., Pellegrino T., Micheel C., Williams S.C., Seitz M., Bruehl R.E., Bryant Z., Bustamante C., Bertozzi C.R., and Alivisatos A.P. Conjugation of DNA to silanized colloidal semiconductor nanocrystalline quantum dots. Chem. Mater. 14 (2002) 2113-2119
53. Akerman M.E., Chan W.C.W., Laakkonen P., Bhatia S.N., and Ruoslahti E. Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. USA 99 (2002) 12617-12621
54. Hanaki K.I., Momo A., Oku T., Komoto A., Maenosono S., Yamaguchi Y., and Yamamoto K. Semiconductor quantum dot/albumin complex is a long-life and highly photostable endosome marker. Biochem. Biophys. Res. Commun. 302 (2003) 496-501
55. Goldman E.R., Anderson G.P., Tran P.T., Mattoussi H., Charles P.T., and Mauro J.M. Conjugation of luminescent quantum dots with antibodies using an engineered adaptor protein to provide new reagents for fluoroimmunoassays. Anal. Chem. 74 (2002) 841-847
56. Parak W.J., Pellegrino T., and Plank C. Labelling of cells with quantum dots. Nanotechnology 16 (2005) R9-R25
57. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., Sundaresan G., Wu A.M., Gambhir S.S., and Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307 (2005) 538-544
58. Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., and Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21 (2005) 10644-10654
59. Gupta A.K., and Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26 (2005) 3995-4021
60. Derfus A.M., Chan W.C.W., and Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 4 (2004) 11-18
61. Pradhan N., Goorskey D., Thessing J., and Peng X. An alternative of CdSe nanocrystal emitters: pure and tunable impurity emissions in ZnSe nanocrystals. J. Am. Chem. Soc. 127 (2005) 17586-17587
62. Kirchner C., Liedl T., Kudera S., Pellegrino T., Javier A.M., Gaub H.E., Stoelzle S., Fertig N., and Parak W.J. Cytotoxicity of colloidal cdse and cdse/zns nanoparticles. Nano Lett. 5 (2005) 331-338
63. Hoshino A., Fujioka K., Oku T., Suga M., Sasaki Y.F., Ohta T., Yasuhara M., Suzuki K., and Yamamoto K. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett. 4 (2004) 2163-2169
64. Aldana J., Wang Y.A., and Peng X. Photochemical instability of cdse nanocrystals coated by hydrophilic thiols. J. Am. Chem. Soc. 123 (2001) 8844-8850
65. Parak W.J., Boudreau R., Le Gros M., Gerion D., Zanchet D., Micheel C.M., Williams S.C., Alivisatos A.P., and Larabell C. Cell motility and metastatic potential studies based on quantum dot imaging of phagokinetic tracks. Adv. Mater. 14 (2002) 882-885
66. Hoshino A., Hanaki K.I., Suzuki K., and Yamamoto K. Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body. Biochem. Biophys. Res. Commun. 314 (2004) 46-53
67. Gao X., Cui Y., Levenson R.M., Chung L.W.K., and Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22 (2004) 969-976
68. Voura E.B., Jaiswal J.K., Mattoussi H., and Simon S.M. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat. Med. 10 (2004) 993-998
69. Bharali D.J., Lucey D.W., Jayakumar H., Pudavar H.E., and Prasad P.N. Folate-receptor-mediated delivery of inp quantum dots for bioimaging using confocal and two-photon microscopy. J. Am. Chem. Soc. 127 (2005) 11364-11371
70. Lovric J., Cho S.J., Winnik F.M., and Maysinger D. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem. Biol. 12 (2005) 1227-1234
71. Ipe B.I., Lehnig M., and Niemeyer C.M. On the generation of free radical species from quantum dots. Small 1 (2005) 706-709
72. Chan W.-H., Shiao N.-H., and Lu P.-Z. CdSe quantum dots induce apoptosis in human neuroblastoma cells via mitochondrial-dependent pathways and inhibition of survival signals. Toxicol. Lett. 167 (2006) 191-200
73. Green M., and Howman E. Semiconductor quantum dots and free radical induced DNA nicking. Chemical Comm. (Cambridge, England) (2004) 121-123
74. Zhang T., Stilwell J.L., Gerion D., Ding L., Elboudwarej O., Cooke P.A., Gray J.W., Alivisatos A.P., and Chen F.F. Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. Nano Lett. 6 (2006) 800-808
75. Pang S.-W., Park H.-Y., Jang Y.-S., Kim W., and Kim J.-H. Effects of charge density and particle size of poly(styrene/(dimethylamino)ethyl methacrylate) nanoparticle for gene delivery in 293 cells. Colloids Surf. B, Biointerf. 26 (2002) 213-222
76. Conner S.D., and Schmid S.L. Regulated portals of entry into the cell. Nature 422 (2003) 37-44
77. Marsh M., and McMahon H.T. The structural era of endocytosis. Science 285 (1999) 215-220
78. Swanson J.A., and Watts C. Macropinocytosis. Trends Cell Biol. 5 (1995) 424-428
79. Shin J.S., and Abraham S.N. CELL BIOLOGY: Caveolae - not just craters in the cellular landscape. Science 293 (2001) 1447-1448
80. Anderson R.G. The caveolae membrane system. Annu. Rev. Biochem. 67 (1998) 199-225
81. Pelkmans L., and Helenius A. Endocytosis via caveolae. Traffic 3 (2002) 311-320
82. Qian Z.M., Li H., Sun H., and Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54 (2002) 561-587
83. Sun C., Sze R., and Zhang M. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J. Biomed. Mater. Res. A 78A (2006) 550-557
84. Sinha R., Kim G., Nie S., and Shin D. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol. Cancer Ther. 5 (2006) 1909-1917
85. Higgins M., and McMahon H. Snap-shots of clathrin-mediated endocytosis. Trends Biochem. Sci. 27 (2002) 257-263
86. Chan Y., Bulmus V., Zareie M.H., Byrne F.L., Barner L., and Kavallaris M. Acid-cleavable polymeric core-shell particles for delivery of hydrophobic drugs. J. Control. Release 115 (2006) 197-207
87. Potineni A., Lynn D.M., Langer R., and Amiji M.M. Poly(ethylene oxide)-modified poly(b-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery. J. Control. Release 86 (2003) 223-234
88. Bae Y., Nishiyama N., Fukushima S., Koyama H., Yasuhiro M., and Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug. Chem. 16 (2005) 122-130
89. Panyam J., Zhou W.-Z., Prabha S., Sahoo S.K., and Labhasetwar V. Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 16 (2002) 1217-1226
90. Lindgren M., Hallbrink M., Prochiantz A., and Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 21 (2000) 99-103
91. Tseng Y.L., Liu J.J., and Hong R.L. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and Tat: a kinetic and efficacy study. Mol. Pharmacol. 62 (2002) 864-872
92. Levchenko T.S., Rammohan R., Volodina N., and Torchilin V.P. Tat peptide-mediated intracellular delivery of liposomes. Methods Enzymol. 372 (2003) 339-349
93. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., and Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18 (2000) 410-414
94. Suk J.S., Suh J., Choy K., Lai S.K., Fu J., and Hanes J. Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles. Biomaterials 27 (2006) 5143-5150
95. Bogoyevitch M.A., Kendrick T.S., Ng D.C.H., and Barr R.K. Taking the cell by stealth or storm? Protein transduction domains (PTDs) as versatile vectors for delivery. DNA Cell Biol. 21 (2002) 879-894
96. Zorko M., and Langel U. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug Deliv. Rev. 57 (2005) 529-545
97. Brooks H., Lebleu B., and Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv. Drug Deliv. Rev. 57 (2005) 559-577
98. Morris M.C., Depollier J., Mery J., Heitz F., and Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19 (2001) 1173-1176
99. Pellegrino T., Parak W.J., Boudreau R., Le Gros M.A., Gerion D., Alivisatos A.P., and Larabell C.A. Quantum dot-based cell motility assay. Differentiation 71 (2003) 542-548
100. Hoshino A., Fujioka K., Kawamura Y.I., Toyama-Sorimachi N., Yasuhara M., Dohi T., and Yamamoto K. Immune cells tracing using quantum dots. Proc. SPIE 6096 (2006) 609613/1-609613/8
101. Silver J., and Ou W. Photoactivation of quantum dot fluorescence following endocytosis. Nano Lett. 5 (2005) 1445-1449
102. Lagerholm B.C., Wang M., Ernst L.A., Ly D.H., Liu H., Bruchez M.P., and Waggoner A.S. Multicolor coding of cells with cationic peptide coated quantum dots. Nano Lett. 4 (2004) 2019-2022
103. Mattheakis L.C., Dias J.M., Choi Y.J., Gong J., Bruchez M.P., Liu J., and Wang E. Optical coding of mammalian cells using semiconductor quantum dots. Anal. Biochem. 327 (2004) 200-208
104. Rozenzhak S.M., Kadakia M.P., Caserta T.M., Westbrook T.R., Stone M.O., and Naik R.R. Cellular internalization and targeting of semiconductor quantum dots. Chem. Commun. (2005) 2217-2219
105. Chang E., Yu W.W., Colvin V.L., and Drezek R. Quantifying the influence of surface coatings on quantum dot uptake in cells. J. Biomed. Nanotechnol. 1 (2005) 397-401
106. Bentzen E.L., Tomlinson I.D., Mason J., Gresch P., Warnement M.R., Wright D., Sanders-Bush E., Blakely R., and Rosenthal S.J. Surface modification to reduce nonspecific binding of quantum dots in live cell assays. Bioconjug. Chem. 16 (2005) 1488-1494
107. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., and Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 15 (2004) 79-86
108. W. Cai, D. Shin, K. Chen, O. Gheysens, Q. Cao, S. Wang, X, S.S. Gambhir, X. Chen, Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects, Nano Lett. 6 (2006) 669-676.
109. Jain R.K. Transport of molecules across tumor vasculature. Cancer Metast. Rev. 6 (1987) 559-593
110. Winter J.O., Liu T.Y., Korgel B.A., and Schmidt C.E. Recognition molecule directed interfacing between semiconductor quantum dots and nerve cells. Adv. Mater. 13 (2001) 1673-1677
111. Wu X., Liu H., Liu J., Haley K.N., Treadway J.A., Larson J.P., Ge N., Peale F., and Bruchez M.P. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol. 21 (2002) 41-46
112. Howarth M., Takao K., Hayashi Y., and Ting A.Y. Targeting quantum dots to surface proteins in living cells with biotin ligase. Proc. Natl. Acad. Sci. USA 102 (2005) 7583-7588
113. Jiang W., Mardyani S., Fischer H., and Chan W.C.W. Design and characterization of lysine cross-linked mercapto-acid biocompatible quantum dots. Chem. Mater. 18 (2006) 872-878
114. Pan Y., Cai J., Qin L., and Wang H. Atomic force microscopy-based cell nanostructure for ligand-conjugated quantum dot endocytosis. Acta Biochim. Biophys. Sin. 38 (2006) 646-652
115. Grecco H.E., Lidke K.A., Heintzmann R., Lidke D.S., Spagnuolo C., Martinez O.E., Jares-Erijman E.A., and Jovin T.M. Ensemble and single particle photophysical properties (two-photon excitation, anisotropy, FRET, lifetime, spectral conversion) of commercial quantum dots in solution and in live cells. Microsc. Res. Tech. 65 (2004) 169-179
116. Mendelsohn J., and Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene 19 (2000) 6550-6565
117. Kriete A., Papazoglou E., Edrissi B., Pais H., and Pourrezaei K. Automated quantification of quantum-dot-labelled epidermal growth factor receptor internalization via multiscale image segmentation. J. Microsc. 222 (2005) 22-27
118. Wang J., Vernier P.T., Sun Y., Gundersen M.A., and Marcu L. A fluorescence microscopy study of quantum dots as fluorescent probes for brain tumor diagnosis. Proc. SPIE 5703 (2005) 127-134
119. Rajan S.S., and Vu T.Q. Quantum dots monitor TrkA receptor dynamics in the interior of neural pc12 cells. Nano Lett. 6 (2006) 2049-2059
120. Humphries M.J. Integrin structure. Biochem. Soc. Trans. 28 (2000) 311-340
121. Koivunen E., Wang B., and Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology 13 (1995) 265-270
122. Pasqualini R., Koivunen E., and Ruoslahti E. av Integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol. 15 (1997) 542-546
123. Leamon C.P., and Low P.S. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov. Today 6 (2001) 44-51
124. Reddy J., Dean D., Kennedy M., and Low P. Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J. Pharm. Sci. 88 (2000) 1112-1118
125. Hilgenbrink A.R., and Low P.S. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J. Pharm. Sci. 94 (2005) 2135-2146
126. Chan W.C.W., Maxwell D.J., Gao X., Bailey R.E., Han M., and Nie S. Luminescent quantum dots for multiplexed biological detection and imaging. Curr. Opin. Biotechnol. 13 (2002) 40-46
127. Ruoslahti E. Targeting tumor vasculature with homing peptides from phage display. Semin. Cancer Biol. 10 (2000) 435-442
128. Krumpe L.R.H., and Mori T. The use of phage-displayed peptide libraries to develop tumor-targeting drugs. Int. J. Peptide Res. Therap. 12 (2006) 79-91
129. Oyama T., Rombel I.T., Samli K.N., Zhou X., and Brown K.C. Isolation of multiple cell-binding ligands from different phage displayed-peptide libraries. Biosensors Bioelectronics 21 (2006) 1867-1875
130. Kim Y., Lillo A.M., Steiniger S.C.J., Liu Y., Ballatore C., Anichini A., Mortarini R., Kaufmann G.F., Zhou B., Felding-Habermann B., and Janda K.D. Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand. Biochemistry 45 (2006) 9434-9444
131. Takeda S., Kadowaki S., Haga T., Takaesu H., and Mitaku S. Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett. 520 (2002) 97-101
132. Cushing B.L., Kolesnichenko V.L., and O'Connor C.J. Recent advances in the liquid-phase syntheses of inorganic nanoparticles. Chem. Rev. 104 (2004) 3893-3946
133. Rosenthal S.J., Tomlinson I., Adkins E.M., Schroeter S., Adams S., Swafford L., McBride J., Wang Y., DeFelice L.J., and Blakely R.D. Targeting cell surface receptors with ligand-conjugated nanocrystals. J. Am. Chem. Soc. 124 (2002) 4586-4594
134. Tomlinson I.D., Mason J.N., Blakely R.D., and Rosenthal S.J. Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots. Bioorg. Med. Chem. Lett. 15 (2005) 5307-5310
135. Tomlinson I.D., Mason J.N., Blakely R.D., and Rosenthal S.J. High affinity inhibitors of the dopamine transporter (DAT): novel biotinylated ligands for conjugation to quantum dots. Bioorg. Med. Chem. Lett. 16 (2006) 4664-4667
136. Mason J.N., Farmer H., Tomlinson I.D., Schwartz J.W., Savchenko V., DeFelice L.J., Rosenthal S.J., and Blakely R.D. Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation. J. Neurosci. Methods 143 (2005) 3-25
137. Young S.H., and Rozengurt E. Qdot nanocrystal conjugates conjugated to bombesin or ANG II label the cognate G protein-coupled receptor in living cells. Am. J. Physiol. 290 (2006) C728-C732
138. Panyam J., and Labhasetwar V. Targeting intracellular targets. Curr. Drug Deliv. 1 (2004) 235-247
139. Fahrenkrog B., and Aebi U. The nuclear pore complex: nucleocytoplasmic transport and beyond. Nat. Rev. Mol. Cell Biol. 4 (2003) 757-766
140. Szewczyk A., and Wojtczak L. Mitochondria as a pharmacological target. Pharmacol. Rev. 54 (2002) 101-127
141. Dias N., and Bailly C. Drugs targeting mitochondrial functions to control tumor cell growth. Biochem. Pharmacol. 70 (2005) 1-12
142. Delehanty J.B., Medintz I.L., Pons T., Brunel F.M., Dawson P.E., and Mattoussi H. Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. Bioconjug. Chem. 17 (2006) 920-927
143. de la Fuente J.M., Fandel M., Berry C.C., Riehle M., Cronin L., Aitchison G., and Curtis A.S.G. Quantum dots protected with tiopronin: a new fluorescence system for cell-biology studies. ChemBioChem 6 (2005) 989-991
144. Santra S., Yang H., Stanley J.T., Holloway P.H., Moudgil B.M., Walter G., and Mericle R.A. Rapid and effective labeling of brain tissue using TAT-conjugated CdS[ratio]Mn/ZnS quantum dots. Chem. Commun. (2005) 3144-3146
145. Gumbleton M., Hollins A.J., Omidi Y., Campbell L., and Taylor G. Targeting caveolae for vesicular drug transport. J. Control. Release 87 (2003) 139-151
146. Damm E.M., Pelkmans L., Kartenbeck J., Mezzacasa A., Kurzchalia T., and Helenius A. Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168 (2005) 477-488
147. Kaplan I.M., Wadia J.S., and Dowdy S.F. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Control. Release 102 (2005) 247-253
148. Ferrari A., Pellegrini V., Arcangeli C., Fittipaldi A., Giacca M., and Beltram F. Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol. Ther. 8 (2003) 284-294
149. Zhang Y., So M.K., and Rao J. Protease-modulated cellular uptake of quantum dots. Nano Lett. 6 (2006) 1988-1992
150. Caruthers S.D., Wickline S.A., and Lanza G.M. Nanotechnological applications in medicine. Curr. Opin. Biotechnol. 18 (2007) 26-30